Amicus Therapeutics Short Interest Increases, but Hedge Funds and Institutional Investors Remain Optimistic
Amicus Therapeutics, Inc. (NASDAQ:FOLD) has experienced a significant increase in short interest during the month of June. According to reports, ...
